Nektar Therapeutics
NKTR· Nasdaq
Released Nov 5, 2015, after the close
10-Q filed Nov 6, 2015, 37 days after period end · 0001193125-15-368796
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $59.95M | $132.87M | $60.91M | $18.41M |
| Net Income | -$8.20M | $70.61M | -$16.54M | -$43.55M |
| EPS Diluted | -$0.06 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| $0.53 |
| -$0.14 |
| -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.